Brief: Jubilant Life Sciences Launches Remdesivir For Injection Under Brand Name 'JUBI-R'
Aug 3 (Reuters) - Jubilant Life Sciences Ltd JULS.NS :
* JUBILANT LIFE SCIENCES LTD SAYS UNIT HAS LAUNCHED
REMDESIVIR
FOR INJECTION UNDER BRAND NAME 'JUBI-R'
* JUBILANT LIFE SCIENCES LTD SAYS LAUNCHED 'JUBI-R' IN
INDIAN
MARKET AT 4,700 RUPEES PER VIAL OF 100 MG
* CO TO MAKE DRUG AVAILABLE TO OVER 1,000 HOSPITALS
PROVIDING
COVID-19 TREATMENT IN INDIA THROUGH DISTRIBUTION NETWORK
Source text for Eikon: ID:nBSE476Ptx
Further company coverage: JULS.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures